- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04001192
Exercise in Patients With Post-Concussion Symptoms
March 13, 2022 updated by: St. Olavs Hospital
Exercise in Patients With Post-Concussion Symptoms - a Pilot Study
Physical activity and exercise have traditionally not been much of a focus in treatment of postconcussion symptoms and posttraumatic headache.
On the contrary, patients have often got advice to rest until they were free from symptoms.
This approach, however, is challenged, and complete rest should probably be discouraged after the first 24-72 hours.
Moderate aerobic exercise has been found promising in the early phase after sports-related concussion, and in the treatment of patients with headache.
This study is an open pilot-study of guided, home-based exercise in a clinical sample with postconcussion symptoms and posttraumatic headache after mixed-mechanism mild traumatic brain injury and minimal head injuries.
The study will result in data about the feasibility and possible effects of exercise as treatment for prolonged postconcussion symptoms and posttraumatic headache.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Trondheim, Norway
- St Olavs Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 65 years (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- having sustained a minimal head injury (according to the Head Injury Severity Scale, HISS) or mild traumatic brain injury (TBI) (according to the TBI definition and the WHO criteria for mild TBI) within the last three years).
- post-concussion symptoms of at least moderate degree (according to the Rivermead postconcussion symptom questionnaire RPCSQ) occurring within the first week after the head injury and/or posttraumatic headache according to the International Classification of Headache Disorders 3 (ICHD-3) criteria.
- outpatients at St Olavs Hospital Clinic of Physical Medicine and Rehabilitation, Department of Acquired Brain Injury
Exclusion Criteria:
- Symptoms better explained by other conditions.
- Severe communication problems, typically due to language problems.
- Severe psychiatric, neurological, somatic or substance abuse disorders that will complicate follow-up and outcome assessment.
- Orthopedic injury or other disability too severe for performing the test or the intervention.
- Cardiovascular conditions or risk factors that are not compatible with testing or safe unsupervised exercise.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: exercise
exercise at home, 5-6 days per week during 12 weeks, guided by a schedule that the physiotherapist will design after initial treadmill testing.
Exercise intensity is 80-90 % of the heart rate threshold that was identified by the treadmill test.
During the 12 weeks program, intensity will be increased according to feedback from the participant.
|
The intervention is exercise at home, 5-6 days per week during 12 weeks, guided by a schedule that the physiotherapist will design after initial treadmill testing.
Exercise intensity is 80-90 % of the heart rate threshold that was identified by the treadmill test.
During the 12 weeks program, intensity will be increased according to feedback from the participant.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The proportion of participants completing the exercise program
Time Frame: 12 weeks
|
12 weeks
|
|
Estimated change in post concussion symptom burden
Time Frame: 12 weeks
|
assessed with Rivermead postconcussion symptom questionnaire (www.tbi-impact.org/cde/mod_templates/12_F_06_Rivermead.pdf) 17 questions about severeness of symptoms, answers 0 (not experienced at all) - 4 (a severe problem).
Ratings on the total symptom scores, and for individual items..
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in posttraumatic headache
Time Frame: 12 weeks
|
Change in number of days with moderate or severe headache during the last 2 weeks
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Bjørn Skogstad, md, St. Olavs Hospital
- Principal Investigator: Toril Skandsen, md phd, St. Olavs Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 14, 2019
Primary Completion (ACTUAL)
July 8, 2021
Study Completion (ACTUAL)
July 8, 2021
Study Registration Dates
First Submitted
June 26, 2019
First Submitted That Met QC Criteria
June 26, 2019
First Posted (ACTUAL)
June 27, 2019
Study Record Updates
Last Update Posted (ACTUAL)
March 15, 2022
Last Update Submitted That Met QC Criteria
March 13, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Pain
- Neurologic Manifestations
- Trauma, Nervous System
- Headache Disorders
- Head Injuries, Closed
- Wounds, Nonpenetrating
- Headache Disorders, Secondary
- Brain Injuries
- Wounds and Injuries
- Brain Injuries, Traumatic
- Headache
- Craniocerebral Trauma
- Post-Concussion Syndrome
- Brain Concussion
- Post-Traumatic Headache
Other Study ID Numbers
- 2018/2159
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Craniocerebral Trauma
-
Nanjing Yoko Biomedical Co., Ltd.Recruiting
-
University Hospital, ToulouseNot yet recruiting
-
Marmara UniversityCompleted
-
Assistance Publique - Hôpitaux de ParisFrancophone Pediatric Resuscitation and Emergency Group (GFRUP)Completed
-
Centre Hospitalier Annecy GenevoisTerminated
-
Rabin Medical CenterIsraeli Ministry of SecurityUnknown
-
Methodist Health SystemRecruiting
-
University Hospital, AngersRecruiting
-
University of North Carolina, Chapel HillUnited States Department of DefenseCompleted
Clinical Trials on aerobic exercise program
-
University of British ColumbiaCompleted
-
Munzur UniversityRecruiting
-
National Cheng-Kung University HospitalMinistry of Science and Technology, TaiwanCompletedEffects of Aerobic Exercise in Pregnant Women
-
Irmandade da Santa Casa de Misericordia de Sao...CompletedAdolescent Idiopathic ScoliosisBrazil
-
Ankara Yildirim Beyazıt UniversityNot yet recruiting
-
Ottawa Hospital Research InstituteCanadian Cancer Trials GroupCompleted
-
Riphah International UniversityCompleted
-
Instituto Nacional de Cancerologia, ColumbiaUniversidad Nacional de ColombiaUnknownStomach Neoplasms | Rectal Neoplasms | Colonic Neoplasms | Liver NeoplasmColombia
-
University of Kansas Medical CenterCompleted
-
University of Arkansas, FayettevilleUnknownDiabetes Mellitus, Type 2, Cognitive Dysfunction, Epigenetics, Exercise